Latest News

FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection

November 20th 2024

The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.

Computed Tomography Study Finds Nearly 44 Percent of Interstitial Lung Abnormalities Are Not Reported
Computed Tomography Study Finds Nearly 44 Percent of Interstitial Lung Abnormalities Are Not Reported

November 20th 2024

Meta-Analysis Assesses Prognostic Role of CT-Based Coronary Artery Calcification in Patients with Lung Cancer
Meta-Analysis Assesses Prognostic Role of CT-Based Coronary Artery Calcification in Patients with Lung Cancer

November 19th 2024

New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging

November 18th 2024

FDA Clears AI Software for Fetal Heart Ultrasound Assessment
FDA Clears AI Software for Fetal Heart Ultrasound Assessment

November 18th 2024

Video Interviews

Latest Conference Coverage

View All
SPECT/CT Device for Theranostic Imaging Debuts at EANM Meeting
SPECT/CT Device for Theranostic Imaging Debuts at EANM Meeting

October 21st 2024

Advances in AI — June 2024
Advances in AI — June 2024

June 26th 2024

Study Examines Prognostic Value of 68Ga-PSMA-11 PET/CT for Patients at High Risk of PCa
Study Examines Prognostic Value of 68Ga-PSMA-11 PET/CT for Patients at High Risk of PCa

June 21st 2024

Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Emerging Research at SNMMI Examines 18F-Flotufolastat in Managing Primary and Recurrent Prostate Cancer

June 13th 2024

All News

© 2024 MJH Life Sciences

All rights reserved.